Core Viewpoint - The announcement details a reduction in shareholding by major shareholders Wang Jiankai and Wang Jianyu, which does not trigger a mandatory takeover bid and does not change the control of the company [3][5]. Group 1: Shareholding Changes - Wang Jiankai and his concerted actor Wang Jianyu collectively hold 58,799,926 shares, representing 25.00% of the total share capital of the company after the reduction [3][4]. - Prior to the reduction, their combined shareholding was 25.77%, indicating a decrease of 0.77% due to the sale of 1,815,450 shares [4][15]. - The reduction plan allows for a maximum of 7,056,000 shares to be sold, equating to 3.00% of the total shares, with specific limits on the methods of sale [14][15]. Group 2: Regulatory Compliance - The company has received the necessary notifications and reports from the shareholders regarding the shareholding changes, ensuring compliance with relevant securities laws [7][9]. - The shareholders have committed to providing accurate and complete information, affirming the absence of misleading statements or omissions [2][10]. Group 3: Future Plans - Wang Jiankai's reduction plan is set to continue until January 21, 2026, with ongoing monitoring of the situation by the company [14][15]. - There are no current plans for increasing shareholdings within the next 12 months, and any future changes will be disclosed in accordance with legal requirements [15].

Core Viewpoint - The announcement details a significant equity change involving Guangdong Anda Intelligent Equipment Co., Ltd., where a shareholder reduced their stake, triggering a notification due to the change crossing a 5% threshold [1][2]. Group 1: Shareholder Information - The shareholder Dongguan Yizhitong Industrial Investment Partnership (Limited Partnership) reduced its holdings by 1,491,550 shares, representing 1.82% of the total share capital [1][2]. - Following the reduction, Yizhitong holds 7,509,710 shares, which is 9.14% of the total share capital, while the combined holdings of Yizhitong and its concerted actors decreased from 71.82% to 70.00% [1][2]. Group 2: Equity Change Details - The equity change was executed through a block trade on December 15, 2025, and is part of a previously disclosed share reduction plan [2][3]. - The reduction does not trigger a mandatory tender offer and will not alter the company's controlling shareholder or actual controller [2][3]. Group 3: Future Plans - Yizhitong has a plan to further reduce its holdings by up to 2,250,315 shares, which is approximately 2.74% of the total shares, within the disclosed reduction period [11]. - As of the report date, the reduction plan has not been fully executed, and there are no current plans to increase or further decrease holdings beyond the disclosed plan [11][12]. Group 4: Compliance and Legal Framework - The equity change complies with the relevant laws and regulations, including the Securities Law of the People's Republic of China and the Management Measures for the Acquisition of Listed Companies [2][3]. - The information disclosure obligations have been met, and there are no violations of previous commitments by the information disclosing parties [2][3].

Group 1 - The core point of the announcement is that Shanghai Anze Private Fund Management Co., Ltd. plans to reduce its shareholding in Saily Medical Technology Group Co., Ltd. by up to 4,202,784 shares, which represents 2% of the company's total share capital, due to its investment planning arrangements [2][10]. - The reduction will occur over a three-month period from October 30, 2025, to January 29, 2026, through centralized bidding and block trading methods [2][11]. - As of December 11, 2025, Shanghai Anze has already reduced its holdings by 1,591,200 shares, bringing its ownership down from 5.76% to 5% [2][14]. Group 2 - The reduction in shareholding does not trigger a mandatory tender offer and will not lead to changes in the company's controlling shareholder or actual controller [3][4]. - The company will ensure that Shanghai Anze complies with relevant regulations during the reduction period and will disclose information to investors [4][11]. - The total share capital of Saily Medical was 210,139,246 shares as of August 20, 2025, and increased to 210,183,386 shares by December 10, 2025, affecting the percentage calculations [2][15].

Core Viewpoint - The announcement details a significant reduction in shareholding by a major shareholder, Sichuan Development Securities Investment Fund Management Co., Ltd., which has decreased its stake in Chengdu Sanno Biological Technology Co., Ltd. from 7.0000% to 4.9999%, thus falling below the 5% threshold for major shareholders [2][3][11]. Group 1: Shareholder Information - The shareholder involved in the reduction is Sichuan Development Securities Investment Fund Management Co., Ltd., representing the Sichuan Capital Market Relief Development Securities Investment Fund Partnership (Limited Partnership) [2]. - There are no concerted actions with other shareholders in this reduction [2]. Group 2: Details of the Equity Change - The reduction occurred between September 18, 2025, and December 10, 2025, with a total of 3,147,896 shares sold, accounting for 2.0001% of the company's total share capital [2]. - Following this transaction, the number of shares held by the shareholder decreased from 11,016,995 shares to 7,869,099 shares [2][11]. Group 3: Impact and Future Plans - This equity change does not trigger a mandatory tender offer and will not result in a change of control or significant impact on the company's governance structure or ongoing operations [3]. - The shareholder's reduction plan is part of a previously disclosed strategy due to funding needs, with a potential for further reductions not exceeding 4,721,578 shares (3% of total share capital) within the next 12 months [9].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688719 证券简称：爱科赛博 公告编号：2025-077 西安爱科赛博电气股份有限公司 关于公司股东权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次权益变动系西安爱科赛博电气股份有限公司（以下简称"公司"）股东深圳市达晨创通股权投资企 业(有限合伙)（以下简称"达晨创通"）、深圳市达晨创鸿私募股权投资企业(有限合伙)（以下简称"达晨 创鸿"）作为一致行动人履行此前披露的减持股份计划所致，不触及要约收购。 ● 本次权益变动后，信息披露义务人持有上市公司股份5,769,181股，占上市公司总股本的4.9999%。 ● 本次权益变动为公司持股5%以上非第一大股东正常减持行为，不会对公司治理结构及持续经营产生 重大影响，不会导致公司控股股东、实际控制人发生变化。 公司于2025年12月10日收到股东达晨创通、达晨创鸿发来的《西安爱科赛博电气股份有限公司简式权益 变动报告书》，现将其有关权益变动情况公告如下： 一、本次权益变 ...

Group 1 - The core point of the announcement is that the major shareholder, Sanlin Wanye (Shanghai) Enterprise Group Co., Ltd., has reduced its shareholding in Shanghai Xian Dao Ji Dian Technology Co., Ltd. from 7.00% to 5.85%, which triggers a 1% threshold for equity changes [2][3][4] - Sanlin Wanye plans to reduce its holdings by up to 25,676,000 shares, representing a maximum of 2.76% of the company's total share capital, through both centralized bidding and block trading [2] - The reduction includes a maximum of 9,110,000 shares (0.98% of total shares) through centralized bidding and 16,566,000 shares (1.78% of total shares) through block trading within any consecutive 90-day period [2] Group 2 - From October 24, 2025, to December 10, 2025, Sanlin Wanye has reduced its holdings by 3,617,000 shares (0.39% of total shares) through centralized bidding and 7,039,300 shares (0.76% of total shares) through block trading [3] - After the equity change, Sanlin Wanye's shareholding decreased from 65,140,321 shares to 54,484,021 shares [3] - The equity change is part of the previously disclosed reduction plan and does not trigger a mandatory tender offer, nor does it significantly impact the company's governance structure or ongoing operations [3][4]

国泰海通证券股份有限公司关于公司实际控制人之一致行动人权益变动的提示性公告 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601211 证券简称：国泰海通公告编号：2025-106 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次权益变动不属于增持或者减持，不触及要约收购。 本次权益变动不会使公司控股股东及实际控制人发生变化。 ■ 本次权益变动后，国际集团及其一致行动人仍将合计持有公司3,320,499,533股A股（约占公司股份总数 的18.84%）和276,000,000股H股（约占公司股份总数的1.57%），合计持股比例仍为20.40%，保持不 变。 ■ 二、本次权益变动所涉及的后续事项 上述股东权益变动事项，不会导致公司控股股东、实际控制人发生变化。 本次权益变动为公司实际控制人国际集团之一致行动人之间发生的股份无偿划转，不会使国际集团及其 一致行动人所持公司股份合计数量发生变化，不涉及股份增持或者减持，不触及要约收购，无需进行权 益变动报告书披露等后续工作。 本次权益变动为公司实际控 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601188 证券简称：龙江交通 公告编号：临2025-063 黑龙江交通发展股份有限公司 关于持股5%以上股东权益变动的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 信息披露义务人1： 重要内容提示： ● 本次权益变动为黑龙江交通发展股份有限公司（以下简称"公司"）持股5%以上股东穗甬控股有限公 司（以下简称"穗甬控股"）减持公司股份所致，不触及要约收购。 ● 本次权益变动后，穗甬控股及其一致行动人广州辰崧投资合伙企业（有限合伙）（以下简称"广州辰 崧"）合计持有公司无限售条件流通股50,090,000股，占公司总股本的3.84%。 ● 本次权益变动为公司持股5%以上非第一大股东减持，不会使公司控股股东、实际控制人发生变化。 公司于2025年12月4日收到持股5%以上股东穗甬控股发来的《关于权益变动的告知函》和《简式权益变 动报告书（穗甬控股、广州辰崧）》，获悉其于2025年8月29日一2025年12月3日期间，通过集中竞价方 式减持其持有的15,7 ...

Core Viewpoint - Zhongju High-tech Industrial (Group) Co., Ltd. announced a shareholding increase plan by its largest shareholder, Zhongshan Torch Group Co., Ltd., intending to buy back shares worth between RMB 200 million and RMB 400 million over the next 12 months, which will increase the shareholding percentage from 21.03% to 22.07% [1][3]. Group 1: Shareholding Increase Plan - The largest shareholder, Zhongshan Torch Group, plans to increase its stake in Zhongju High-tech from September 1, 2025, for a period of 12 months [1]. - The planned investment amount for the share buyback is set between RMB 200 million and RMB 400 million [1]. - This increase in shareholding will not trigger a mandatory tender offer [1][3]. Group 2: Impact on Shareholding Structure - Following the share buyback, the shareholding percentage of Zhongshan Torch Group and its concerted actions will rise from 21.03% to 22.07% [1]. - The total share capital of Zhongju High-tech will be adjusted from 778,991,206 shares to 778,509,228 shares due to the cancellation of restricted stock [2]. Group 3: Compliance and Future Actions - The shareholding increase plan is part of a strategy to optimize the capital structure and promote high-quality development of the company [3]. - The company will continue to monitor the implementation of the share buyback plan and fulfill its information disclosure obligations in accordance with relevant laws and regulations [4].

Core Viewpoint - The announcement from New Zhisoft indicates that shareholders OCIL, AL, and CEL, acting in concert, executed a reduction plan, selling a total of 1.8135 million shares, which represents 0.6898% of the total share capital [1] Summary by Relevant Sections - **Shareholder Actions** - Shareholders OCIL, AL, and CEL reduced their holdings from a combined 5.6898% to 5% through the sale of 1.8135 million shares between September 10 and December 3, 2025 [1] - Only AL participated in the reduction, while OCIL and CEL did not sell any shares [1] - **Impact on Shareholding Structure** - The reduction in shareholding means that the three shareholders are no longer considered as a group holding more than 5% of the shares [1] - This change does not trigger a mandatory tender offer and will not lead to changes in the controlling shareholder or actual controller [1] - **Company Governance and Compliance** - The company will continue to monitor the compliance of the shareholders with the reduction plan and ensure that they disclose relevant information [1]